Each filer's latest filing for 03770N101 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| BlackRock, Inc. 13G/A | 5.5% |
7/16/2025
Event 6/30/2025
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (8) | ||||
|
RTW Investments, LP
13G/A
|
4.9% |
2/17/2026
Event 12/31/2025
|
||
| RTW Investments, LP | 4.9% | |||
| Roderick Wong | 4.9% | |||
| Driehaus Capital Management LLC 13G/A | 4.7% |
11/14/2025
Event 9/30/2025
|
||
|
FMR LLC
13G/A
|
4.0% |
7/8/2026
Event 6/30/2026
|
||
| FMR LLC | 4.0% | |||
| Abigail P. Johnson | 4.0% | |||
| T. Rowe Price Investment Management, Inc. 13G/A | 1.3% |
7/8/2026
Event 6/30/2026
|
||
|
Wellington Management Group LLP
13G/A
|
0.9% |
7/8/2026
Event 6/30/2026
|
||
| Wellington Management Group LLP | 0.9% | |||
| Wellington Group Holdings LLP | 0.9% | |||
| Wellington Investment Advisors Holdings LLP | 0.9% | |||
|
Fairmount Funds Management LLC
13D/A
|
0% |
9/3/2026
Event 9/3/2026
|
||
| Fairmount Funds Management LLC | 0% | |||
| Fairmount Healthcare Fund II L.P. | 0% | |||
| Peter Evan Harwin | 0% | |||
| Tomas Kiselak | 0% | |||
| Vanguard Group Inc 13G/A | 0% |
3/26/2026
Event 3/13/2026
|
||
|
Venrock Healthcare Capital Partners III, L.P.
13D/A
|
0% |
9/8/2026
Event 9/3/2026
|
||
| Venrock Healthcare Capital Partners III, L.P. | 0% | |||
| VHCP Co-Investment Holdings III, LLC | 0% | |||
| Venrock Healthcare Capital Partners EG, L.P. | 0% | |||
| VHCP Management III, LLC | 0% | |||
| VHCP Management EG, LLC | 0% | |||
| Bong Y. Koh | 0% | |||
| Nimish Shah | 0% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 2 | 8.21 k | $334k |
| 2026 Q2 | 298 | 71.0 M | $9.38B |
| 2026 Q1 | 230 | 79.1 M | $6.64B |
| 2025 Q4 | 211 | 71.3 M | $5.34B |
| 2025 Q3 | 174 | 59.6 M | $2.37B |
| 2025 Q2 | 184 | 57.8 M | $2.51B |
| 2025 Q1 | 172 | 61.5 M | $2.30B |
| 2024 Q4 | 160 | 57.9 M | $2.62B |
| 2024 Q3 | 142 | 56.1 M | $3.29B |
| 2024 Q2 | 140 | 54.2 M | $2.13B |
| 2024 Q1 | 142 | 52.9 M | $3.52B |
| 2023 Q4 | 86 | 41.8 M | $1.16B |
| 2023 Q3 | 74 | 40.1 M | $849M |